Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Venn

Venn?uq=8lCq2teR
2017 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$50K LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of biomarker and target discovery platform intended to diagnose cancer. The company's platform focuses on the identification, quantification and classification of glycoproteomic and other PTM signals found in human blood and tissue for target discovery and validation, enabling healthcare providers to diagnose cancer at an early stage and cure their patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Diagnostic Equipment
Other Healthcare Services
Primary Office
  • 1001 Bayhill Drive
  • 2nd Floor
  • San Bruno, CA 94066
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Venn’s full profile, request a free trial.

Venn Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator $50K 0000 00000 Completed Startup
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Venn Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Boost VC Accelerator/Incubator Minority 000 0000 000000 0
Founders Fund Venture Capital Minority 000 0000 000000 0
Prado SV Venture Capital Minority 000 0000 000000 0

Venn Executive Team (2)

Name Title Board
Seat
Contact
Info
Aldo Carrascoso Founder & Chief Executive Officer
Hui Xu Executive